GINA strategy report published
This article provides a summary of key changes in the GINA report, and their rationale.
The changes to the updated guide include
- revised asthma definition
- tools for assessing symptom control and risk factors for adverse outcomes
- expanded indications for inhaled corticosteroid therapy
- framework for targeted treatment based on phenotype, modifiable risk factors, patient preference, and practical issues
- optimisation of medication effectiveness by addressing inhaler technique and adherence
- revised recommendations about written asthma action plans
- diagnosis and initial treatment of the asthma−chronic obstructive pulmonary disease overlap syndrome
- diagnosis in wheezing pre-school children
- updated strategies for adaptation and implementation of GINA recommendations.
